HOME › DRUGS › TEPROTUMUMAB
ACTIVE SUBSTANCE / INN

TEPROTUMUMAB

Brand name(s): Tepezza
EMA LISTED
AUTHORISED
Graves Ophthalmopathy
ACTIVE SUBSTANCE
Teprotumumab
REGULATORS
EMA
SPONSORS / MAH
Amgen Europe B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TepezzaAmgen Europe B.V.Authorised19/06/2025Graves Ophthalmopathy

FULL INTELLIGENCE ON TEPROTUMUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →